FOXP3 and COVID-19: Analysis of regulatory T cells (Tregs) revealed decrement in percentage of CD4+ FoxP3+ T cells as well as in percentage of CD4+ IL-10 producing T cells (data not shown) in terminal stage of COVID-19.